At Mydecine, we see the future of digital healthcare. This future is enhanced by automation, augmented by data, and holistic in its consideration of the relationship between body and mind. With these principles in mind, we recognize that an immense potential exists for developing and delivering new technology solutions for mental health, and for delivering these solutions on a global scale.
We are focused on the rapidly evolving categories of psychedelic-derived medicines, digital therapeutics, and quantified mental health. Our first breakthrough digital technology is Mindleap: an advanced mental healthcare system that combines all three of these areas into a single platform.